Posts Tagged ‘terapio’

Austin Technology Incubator Holds Graduation For 21 Companies, Celebrates Beginning 23rd Year of Incubating Central Texas Companies

Thursday, January 19th, 2012

One week from today, the Austin Technology Incubator (ATI), a not-for-profit unit of the IC2 Institute of The University of Texas at Austin (UT), will host a graduation and alumni event to celebrate more than two decades of incubating Central Texas technology companies.  On January 26, at the AT&T Executive Education and Conference Center at The University of Texas at Austin, ATI will recognize the “graduation” of 21 companies who have moved on from ATI over the past few years.

ATI will also announce the winner of the Laura J Kilcrease Civic Entrepreneurship Award. And, for the first time in many years, ATI will bring
together over 300 of the hundreds of technology influencers who have been part of the ATI family as executives of portfolio companies, advisors, investors, business partners, UT student interns, and ATI staff.  This alumni gathering will celebrate the community that ATI has created and hundreds of amazing business successes ATI has had a hand in.

The 21 companies to be honored as ATI graduates on January 26 include businesses focused on information technology, wireless, clean energy, and biosciences technology.  They are:

  • Agile Planet
  • Atonometrics
  • Axelo
  • Calxeda
  • Dorsan Biofuels
  • Famigo
  • Firefly LED Lighting
  • GameSalad
  • Ideal Power Converters
  • itzbig
  • Nitero
  • Notice Technologies
  • OpenAlgae
  • Qcue
  • RFMicron
  • RRE Solar
  • Savara Pharmaceuticals
  • Spredfast
  • Terapio
  • Unwired Nation
  • WiMax.com

View the full press release at http://www.prweb.com/releases/2012/1/prweb9120155.htm.

Press interested in attending the January 26th event and/or speaking with executives from ATI or the graduating companies can contact Laura Beck at 512-786-1098 or laurabeckcahoon@gmail.com.

Here comes the sun?

Monday, December 21st, 2009

barchas-isaac

Here comes the sun?

Well, was that ever a tough year!  Capital markets melted down, customers went into lock-down mode, and many of us (and our investors) lost a big chunk of our personal net worth.  The entrepreneurial ecosystem just seemed to freeze up.

Just recently, though, I see the ice is slowly melting.  ATI companies are getting wins again, in bunches.  Some examples from the past few weeks:

  • Terapio raised a $5 million series A.
  • Savara closed their own A round above their target.
  • Notice Technologies and InXero signed major first customers.
  • eVapt was acquired (the first exit we’ve seen in quite some time!)

In addition to these wins in the private markets, ATI companies continue to compete successfully for public dollars.  This quarter:

We also admitted a number of very exciting new companies in the second half of the year.  We will be highlighting some of them in future newsletters and on this blog.

I’m not ready to say “it’s alright,” yet.  I don’t think any of us know what the economy is going to do.  Moreover, after more than a year of freeze, a number of our companies face urgent challenges.

But I have been seeing smiles returning to a lot more faces around here.  Maybe the momentum has shifted and the sun really is coming out again.  Let’s hope so!

Happy New Year,

–Isaac

Austin-based biotech startup gets $5 million

Tuesday, December 1st, 2009

ATI Member Company, Terapio, announced that it raised $5 million in equity financing from Sante Ventures!  Curt Bilby is a well respected, serial entrepreneur in Austin.  Check out the full press release and here’s and excerpt of the story as reported on the Statesman:

Austin-based biotech startup gets $5 million

Santé Ventures backs Terapio in developing therapeutic applications line.

By Lori Hawkins
AMERICAN-STATESMAN STAFF
Monday, November 30, 2009

Austin-based biotech startup Terapio Corp. plans to announce today that it has raised $5 million to continue developing a line of therapeutic applications.

Terapio received the funding from Austin-based Santé Ventures, which invests in medical technology and health care services companies.

Terapio, which was founded in 2005, is using research licensed from the University of Texas at Arlington to develop an oral medication that would treat people who are exposed to lethal doses of radiation. The company is also developing a method of delivering drugs to the brain and other major organs.

Read more…